EMA management board nominates Rasi as exec director; FDA approves Allergan's Juvederm in lips;

@FiercePharma: Sun Pharmaceutical's Shanghvi drops from top spot in Forbes India rich list. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: ICYMI: Merck KGaA counts on Latin America to power consumer-health future. Article | Follow @CarlyHFierce

> The European Medicines Agency's (EMA) management board has nominated Guido Rasi as its executive director. Release

> The FDA has approved Allergan's Juvederm Ultra XC for use in the lips. Release

> Hi-Tech Pharmaceuticals has filed a lawsuit against Dynamic Sports Nutrition over allegations of Racketeer Influenced and Corrupt Organizations (RICO), trademark infringement and deceptive advertising. Release

> Association of the British Pharmaceutical Industry (ABPI) CEO Stephen Whitehead has left the organization. Report

> Early medication-fill patterns can predict future adherence, a study from the CVS Health Research Institute and Brigham and Women's Hospital says. More

> Bayer's plastics business whittled down its IPO's planned share sale to €1.5 billion ($1.7 billion) from €2.5 billion, in part because of the impact of the emissions scandal surrounding Volkswagen, a major customer. Report

Medical Device News

@FierceMedDev: From FierceDrugDelivery: Intarcia buys Phoundry in search of additional diabetes drugs for its subdermal drug pump. Story | Follow @FierceMedDev

@VarunSaxena2: Study: Oraya radiation tech reduces need for eye injections in AMD patients. Article | Follow @VarunSaxena2

@EmilyWFierce: ICYMI from FiercePharma: New Hampshire AG launches investigation into opioid marketing. Article | Follow @EmilyWFierce

> Neuravi ready to take on Medtronic, Stryker in burgeoning market for devices to fight stroke. More

Biotech News

@FierceBiotech: Fierce's coverage of the Martin Shkreli saga. More | Follow @FierceBiotech

@JohnCFierce: Ladies and gentlemen, the 2015 Fierce 15. Special report | Follow @JohnCFierce

> Sarepta gets creative in bolstering its case for quick eteplirsen approval. Report

> Genentech embraces Arvinas with $300M tie-up on protein degradation. Story

> Facing a crisis, Xoma buys time with a $517M Novartis deal. Article

Vaccines News

> Novavax's RSV jab protects infants in PhII, nets $89M Gates Foundation grant. Article

> Advaxis targets HER2 cancers with first-in-human vaccine trial. Story

> BiondVax, EU's UNISEC team up for universal flu jab PhIIb. More

> PRA Health joins with clinical research network to improve vaccine studies. Item

> NewLink wins $26.1M in government funding to advance Ebola vaccine. Report

CRO News

> Frontage doubles its bioanalytics space. Item

> Accelovance snags another Big Pharma cancer vet to boost its onco profile. Report

> PRA partners up to accelerate vaccine R&D. More

> Patheon rebrands with a $100M IPO in the works. Story

> Chiltern expands in diabetes after a big buyout. Article

Pharma Manufacturing News

> Siegfried completes $302M deal for BASF API plants. News

> EPA presents Pfizer with $194M bill to cleanup former American Cyanide site. Report

> Abbott said to expand manufacturing, other operations in India. Story

> Will a desktop device that synthesizes lidocaine revolutionize pharma manufacturing? More

> Hovione set to expand its NJ facility and add new spray dryer. Article

Pharma Asia News

> China slaps Fosun Pharma unit with small fine for anti-monopoly violations. News

> Singapore's Biosensors launches sales of BMX-J stent in key Japan market. More

> Australia's Paranta Biosciences raises A$7M for PhI of cystic fibrosis candidate. Report

> China biotech CARsgen inks deal with Shanghai Cancer Institute on candidate focus. Story

> MSF campaigns at UN summit meeting to ease pressure on India's drug IP policies. Article

And Finally... Deleted quality tests in China have put the FDA on notice. Report